Business review P08P57 Governance and remuneration P58P101 Financial statements P102P191 Shareholder information P192P212 101 Remuneration Report The transfer values for Andrew Witty and Julian Heslop are Directors and Senior Management calculated in accordance with pensions regulation and represent Further information is also provided on compensation and interests the present value of potential payments under the pension plan.
OF $IRECTORS AND 3ENIORANAGEMENT AS A GROUP @THE GROUP The actuarial assumptions for the calculation have changed since For this purpose, the group is dened as the Executive and 31ST $ECEMBER AND these changes have increased the.
ON %XECUTIVE $IRECTORS AND MEMBERS OF THE #%4 &OR THE lNANCIAL transfer VALUES BY a 6 63% of increase for Andrew Witty year 2010, the total compensation paid to members of the group and 778,368 52% of increase for Julian Heslop.
The balance of for the periods during which they served in that capacity was the increase in transfer value is the result of the increased valuation 20,377,021, the aggregate increase in accrued pension benets, of the pension benefit accrued in the year and the reduced period NET OF INmATION WAS a AND THE AGGREGATE PAYMENT TO of service to the assumed retirement age.
"DElNED CONTRIBUTION SCHEMES WAS a $RONCEF 3LAOUI IS A MEMBER OF THE 53 %XECUTIVE #ASH ""ALANCE $URING THE MEMBERS OF THE GROUP WERE GRANTED Pension Plan."
The plan provides for an Executive Pension Credit, SHARE OPTIONS AND !$3 OPTIONS UNDER THE 3HARE PTION Plan, under which GSK makes annual contributions calculated as a were awarded SHARES UNDER THE $EFERRED !NNUAL Bonus percentage of the executives base salary.
GSK makes contributions Plan, SHARES AND !$3 UNDER THE 0ERFORMANCE at 38% of base pay.
The fund increases at an interest rate set Share Plan, and NIL SHARES AND !$3 UNDER THE 3HARE 6ALUE annually in advance based on the 30 year US Treasury bond rate to 0LAN.
O NOTIONAL SHARES OR !$3 WERE GRANTED UNDER THE $EFERRED provide a cash sum at retirement.
The plan has no entitlement to a Investment Award Plan in 2010.
Members of the group were spouses pension or to pension increases.
"awarded through the reinvestment of dividends with 131,316 shares and 40,260 !$3 IN THE 0ERFORMANCE 3HARE 0LAN, 616 shares 4HE TRANSFER VALUE OR CASH SUM HAS INCREASED BY FOR in tHE $EFERRED !NNUAL ""onus Plan and 5,521 notional shares in $RONCEF 3LAOUI OVER THE YEAR AS A RESULT OF FURTHER ACCUMULATION THE $EFERRED NVESTMENT !WARD 0LAN of interest and contributions paid by the company."
"At 24th February 2011, the group comprising 2 persons owned $RONCEF 3LAOUI WAS AN ACTIVE PARTICIPANT IN THE ""ELGIUM &ORTIS shares and 57 !$3 CONSTITUTING LESS THAN 1% of Plan until 31st May 2006."
This plan is a dened benefit plan with the issued share capital of the company.
The group also held, at a lump sum payable at normal retirement which is age 60 for that date: options to purchase 6,452,022 shares and THE PLAN 4HE TRANSFER VALUE OR CASH SUM OF $RONCEF 3LAOUI S !$3 4,747,585 shares and !$3 AWARDED UNDER THE plan has increased by OVER THE YEAR AS A RESULT OF FURTHER 0ERFORMANCE 3HARE 0LAN INCLUDING THOSE SHARES AND !$3 THAT ARE accumulation of interest.
vested and deferred: 1,350 VESTED AND DEFERRED !$3 UNDER THE $RONCEF 3LAOUI IS A MEMBER OF THE 53 2ETIREMENT 3AVINGS 0LAN legacy SmithKline Beecham Mid-Term Incentive Plan: 13,510 shares a 401k savings scheme open to all US employees and the Executive and 3,730 !$3 AWARDED UNDER THE 3HARE 6ALUE 0LAN: 88,315 shares Supplemental Savings Plan, a savings scheme open to executives AND !$3 UNDER THE $EFErred Annual Bonus Plan and 1,561 to accrue benets above US government limits imposed on the NOTIONAL SHARES AWARDED UNDER THE $EFERRED NVESTMENT !WARD Retirement Savings Plan.
Contributions to both plans are invested Plan.
These holdings were issued under the various executive share in a range of funds and the value of the accumulated funds is paid option plans described in Note 42 to the financial statements, at retirement.
$URING CONTRIBUTIONS OF a WERE PAID INTO Basis of preparation THESE TWO SCHEMES BY '3 IN RESPECT OF $RONCEF 3LAOUI The Remuneration Report has been prepared in accordance with the Companies Act 2006 and The Large and Medium-sized Directors interests in contracts Companies and Groups Accounts and Reports Regulations 2008 Except as described in Note 35 to the financial statements, Related the Regulations and meets the relevant requirements of the FSA party transactions, during or at the end of the financial year no Listing Rules.
In accordance with the Regulations, the following $IRECTOR OR CONNECTED PERSON HAD ANY MATERIAL INTEREST IN ANY sections of the Remuneration Report contract of signicance in relation to the Groups business with a ARE SUBJECT TO AUDIT !NNUAL REMUNERATION.
ON %XECUTIVE $IRECTORS Group company.
remuneration: Incentive plans Share Options: Performance Share Plan awards and their vesting criteria: Share Value Plan awards and Pension benets for which the opinion thereon is expressed on page 187.
The remaining sections are not subject to audit nor are the pages referred to from within the audited sections.
The Remuneration Report has been approved by the Board of $IRECTORS AND SIGNED ON ITS BEHALF BY Sir Crispin Davis Remuneration Committee Chairman 1st March 2011 GSK Annual Report 2010
